Allorion Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 24, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founders
- Peter Ding
- Company Description
- Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
- Market
- Pharmaceuticals
- Location
- Natick, MA, USA
- Coinvestors
- Elikon Venture, Firstred Capital, IDG Capital Partners, Med-Fine Capital, Octagon Capital, Qiming Venture Partners, TF Capital